Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Finance

Reading Time: < 1 minute

Featured content in this Issue:

Canada’s First Published Psilocybin Trial: Includes Patients with BDII and Personality Disorders, Employs Flexible Repeat Dosing Protocol
University of Maryland Joins Terran Biosciences’ Complaint Against Compass Pathways
Further Reading & Other Stories

This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Comments
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Name
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Curtin University, Draslovka partner to advance glycine leaching technology

Reading Time: < 1 minute“The non-toxic amino acid has the potential to replace hazardous chemicals like cyanide in mineral

November 23, 2024

Psychedelic Santa Cruz – Using Psychedelics Daily for a happy & healthy life

Reading Time: < 1 minuteOur mission is to create community surrounding psychedelics, mental health, and spiritual growth. We’ll be

November 22, 2024

How to Process Payments for Your Cannabis Dispensary

Reading Time: 4 minutesHow to Process Payments for Your Cannabis Dispensary Cannabis dispensaries are becoming more common as